Module 1- Welcome note: Dr Shubhi from Medical Learning Hub welcomed the participants and the speakers Dr Rajendra Prasad and Dr Rupak Singla describing the general instructions and the first poll was raised.
Module 2- FAQ in management of MDR TB: Dr Rajendra Prasad; Director Medical Education & Head, Pulmonary Medicine, Era’s Lucknow Medical College & Hospital, Era University; Lucknow. He discussed about the management of MDR TB. Key points discussed by him were:
- Tuberculosis
- TB deaths
- MDR TB globally
- Factors promoting death
- Drug resistance TV
- MDR TB
- XDR TB
- Molecular diagnosis
- First and second line drugs
- TB drug regimen
- Short oral regimen
- Role of surgery
- DR TB treatment future
Module 3- FAQ in use of Delamanid: Dr Rupak Singla; Professor and Head, Department of TB & Resp. Diseases at National Institute Tuberculosis & Respiratory Diseases, New Delhi. He discussed about the use of Delamanid. Key points discussed by him were:
- Mycobacterial activity
- Activity against intracellular mycobacterial
- Delamanid culture conversion studies
- Delamanid trial (safety results)
- Primary, secondary and exploratory end polls
- Trial 213
- Evaluating new approved drugs
- Other FAQ’s related to delamanid
Module 4- Q&A sessions: Several questions were asked during the session which were all answered by the speakers, Dr Rajendra Prasad and Dr Rupak Singla
Module 5- Vote of thanks- After Q&A session vote of thanks was shared by Dr Shubhi from Medical learning Hub and second poll was raised.
We wish you a great learning experience!
We thank Mylan Pharmaceuticals Private Limited, a Viatris Company for supporting us in the webinar
Welcome Note:
Speaker 1: FAQ in management of MDR TB: Dr Rajendra Prasad; Director Medical Education & Head, Pulmonary Medicine, Era’s Lucknow Medical College & Hospital, Era University; Lucknow
Speaker 2: FAQ in use of Delamanid: Dr Rupak Singla; Professor and Head, Department of TB & Resp. Diseases at National Institute Tuberculosis & Respiratory Diseases, New Delhi
Q&A session: Panelist
Vote of Thanks
